Kevin Bitterman

Kevin Bitterman of Cambridge, MA appears across SEC filings — Form ADV advisers, Form D, Reg A, and crowdfunding offerings. Kevin Bitterman appears on 23 filing roles across Form D (22), Form ADV (1).

Registered advisers

Filings (23)

FiledSourceEntityRoleLocation
2025-04-01Form ADVATLAS VENTURE LIFE SCIENCE ADVISORS, LLCMEMBERCAMBRIDGE, MA
2016-04-13Form DKALA BIO, Inc.DirectorARLINGTON, MA
2013-04-04Form DTARIS BIOMEDICAL INCDirectorWALTHAM, MA
2012-11-19Form DVisterra, Inc.DirectorCAMBRIDGE, MA
2010-11-08Form DFollica, IncDirectorMENDHAM, NJ
2015-07-17Form DDirect Vet Marketing, Inc.DirectorPORTLAND, ME
2013-10-10Form DGENOCEA BIOSCIENCES, INC.DirectorCAMBRIDGE, MA
2020-05-07Form DNavitor Pharmaceuticals, Inc.DirectorCAMBRIDGE, MA
2015-08-18Form DEditas Medicine, Inc.DirectorCAMBRIDGE, MA
2016-07-13Form DMorphic Holding, Inc.DirectorWALTHAM, MA
2017-06-30Form DAtlas Venture Fund XI, L.P.Executive OfficerCAMBRIDGE, MA
2018-12-18Form DAkero Therapeutics, Inc.DirectorSouth San Francisco, CA
2019-01-02Form DAtlas Venture Opportunity Fund I, L.P.Executive OfficerCAMBRIDGE, MA
2020-06-04Form DAtlas Venture Fund XII, L.P.Executive OfficerCAMBRIDGE, MA
2023-07-17Form DKinaset Therapeutics, Inc.DirectorMEDFIELD, MA
2021-10-01Form DAtlas Venture Opportunity Fund II, L.P.Executive OfficerCAMBRIDGE, MA
2022-03-03Form DAtlas Venture Fund XIII, L.P.Executive OfficerCAMBRIDGE, MA
2024-08-16Form DJudo Bio Inc.Executive OfficerCAMBRIDGE, MA
2023-09-01Form DChroma Medicine, Inc.DirectorBOSTON, MA
2024-01-04Form DRemix Therapeutics, Inc.DirectorWATERTOWN, MA
2024-12-05Form DAtlas Venture Fund XIV, L.P.Executive OfficerCAMBRIDGE, MA
2025-09-04Form DAtlas Venture Opportunity Fund Ill, L.P.Executive OfficerCAMBRIDGE, MA
2025-07-14Form DRenasant Bio, Inc.DirectorBERKELEY, CA

More